BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29962964)

  • 1. Syndecans and Enzymes Involved in Heparan Sulfate Biosynthesis and Degradation Are Differentially Expressed During Human Odontogenesis.
    Kero D; Bilandzija TS; Arapovic LL; Vukojevic K; Saraga-Babic M
    Front Physiol; 2018; 9():732. PubMed ID: 29962964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndecans and Enzymes for Heparan Sulfate Biosynthesis and Modification Differentially Correlate With Presence of Inflammatory Infiltrate in Periodontitis.
    Duplancic R; Roguljic M; Puhar I; Vecek N; Dragun R; Vukojevic K; Saraga-Babic M; Kero D
    Front Physiol; 2019; 10():1248. PubMed ID: 31611818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of heparan sulfate proteoglycans in murine models of experimental colitis.
    Patterson AM; Delday MI; van Kuppevelt TH; Loh G; Blaut M; Haller D; Grant G; Kelly D
    Inflamm Bowel Dis; 2012 Jun; 18(6):1112-26. PubMed ID: 21987406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and functional analysis of syndecans.
    Park PW
    Methods Cell Biol; 2018; 143():317-333. PubMed ID: 29310785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of syndecan isoforms during mouse incisor amelogenesis.
    Muto T; Miyoshi K; Munesue S; Nakada H; Okayama M; Matsuo T; Noma T
    J Med Invest; 2007 Aug; 54(3-4):331-9. PubMed ID: 17878683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparan sulfate chains with antimitogenic properties arise from mesangial cell-surface proteoglycans.
    Wang A; Miralem T; Templeton DM
    Metabolism; 1999 Oct; 48(10):1220-9. PubMed ID: 10535382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns.
    Kim CW; Goldberger OA; Gallo RL; Bernfield M
    Mol Biol Cell; 1994 Jul; 5(7):797-805. PubMed ID: 7812048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface heparan sulfate proteoglycans control the response of renal interstitial fibroblasts to fibroblast growth factor-2.
    Clayton A; Thomas J; Thomas GJ; Davies M; Steadman R
    Kidney Int; 2001 Jun; 59(6):2084-94. PubMed ID: 11380810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation of genetic polymorphisms in heparan sulfate proteoglycan core proteins and key modification enzymes in an Australian Caucasian multiple sclerosis population.
    Okolicsanyi RK; Bluhm J; Miller C; Griffiths LR; Haupt LM
    Hum Genomics; 2020 May; 14(1):18. PubMed ID: 32398079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syndecan family of cell surface proteoglycans: developmentally regulated receptors for extracellular effector molecules.
    Salmivirta M; Jalkanen M
    Experientia; 1995 Sep; 51(9-10):863-72. PubMed ID: 7556568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific structural features of syndecans and heparan sulfate chains are needed for cell signaling.
    Lopes CC; Dietrich CP; Nader HB
    Braz J Med Biol Res; 2006 Feb; 39(2):157-67. PubMed ID: 16470302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of syndecans to lipoplex-mediated gene delivery.
    Letoha T; Kolozsi C; Ekes C; Keller-pintér A; Kusz E; Szakonyi G; Duda E; Szilák L
    Eur J Pharm Sci; 2013 Jul; 49(4):550-5. PubMed ID: 23732629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular interactions of syndecans during development.
    Rapraeger AC
    Semin Cell Dev Biol; 2001 Apr; 12(2):107-16. PubMed ID: 11292376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndecans in heart fibrosis.
    Lunde IG; Herum KM; Carlson CC; Christensen G
    Cell Tissue Res; 2016 Sep; 365(3):539-52. PubMed ID: 27411689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteoglycans, ion channels and cell-matrix adhesion.
    Mitsou I; Multhaupt HAB; Couchman JR
    Biochem J; 2017 May; 474(12):1965-1979. PubMed ID: 28546458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndecans in cartilage breakdown and synovial inflammation.
    Pap T; Bertrand J
    Nat Rev Rheumatol; 2013 Jan; 9(1):43-55. PubMed ID: 23090508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo activities of heparan sulfate differentially modified by NDSTs during development.
    Nakato E; Baker S; Kinoshita-Toyoda A; Knudsen C; Lu YS; Takemura M; Toyoda H; Nakato H
    Proteoglycan Res; 2024 Jan; 2(1):. PubMed ID: 38616954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndecans as modulators and potential pharmacological targets in cancer progression.
    Barbouri D; Afratis N; Gialeli C; Vynios DH; Theocharis AD; Karamanos NK
    Front Oncol; 2014; 4():4. PubMed ID: 24551591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of ryudocan and syndecan heparan sulfate proteoglycans, core proteins, and cDNAs from a rat endothelial cell line.
    Shworak NW; Kojima T; Rosenberg RD
    Haemostasis; 1993 Mar; 23 Suppl 1():161-76. PubMed ID: 8495865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin.
    Han J; Hiebert LM
    Vascul Pharmacol; 2013; 59(3-4):112-8. PubMed ID: 23939434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.